GATC to highlight its AI-driven addiction
solutions to a national audience attending to learn how to allocate
the tens of billions of dollars resulting from opioid abatement
settlements for states, counties, municipalities and tribes;
Dr. Rahul Gupta, director of the
Office of National Drug Control Policy, will be the
keynote speakers
IRVINE,
Calif., Jan. 24, 2023 /PRNewswire/ -- GATC Health
Corp, a science and technology company revolutionizing drug
discovery and disease prediction using artificial intelligence
(AI), today announced that Tyrone
Lam, COO of GATC Health, will present the company's fentanyl
abatement drug candidates that were identified by GATC's AI-based
drug discovery and development platform. The novel created by GATC
are currently in preclinical drug evaluation studies. Guidelines
allocated a portion of the Opioid Abatement Settlement funds for
research and development, which includes GATC's opioid addiction
abatement projects.
GATC will present AI-driven addiction
solutions to a national audience of states, counties,
municipalities and tribes
The allocation of opioid settlement funds to states has already
begun, yet many states are lagging in their efforts to organize an
adequate abatement plan or council to direct and oversee the
distribution. The Opioid Settlement Abatement
Summit – Model Guidance for States, Counties,
Municipalities and Tribes will take place on Thursday January 26th, 2023 at
Georgetown University and virtually,
and focus on providing model abatement guidance for states,
counties, municipalities and tribes to effectively plan for,
implement and track opioid settlement funds. The goal of the
event is to highlight effective programs, initiatives and tools
that are easily adopted and should be considered in state abatement
plans as funding begins to come in.
The day-long program will emphasize the importance of ensuring
states, counties, municipalities and tribes fully comprehend the
unique opportunity they have to ensure that the settlement funds
they receive are appropriately used to abate the opioid and
overdose crisis in their communities. The program moderator will be
Dr. Stephen Loyd, NSUDSAP Advisory Panel member, Chief Medical
Officer, Cedar Recovery and Chairman of the Tennessee Abatement
Council, along with Dr. Rahul Gupta
(ONDCP) and Regina LaBelle
(O'Neill Institute) as our keynote speakers. The agenda will
include a series of additional prominent speakers with expertise in
priority areas related to opioid abatement efforts covering topics
such as, the Recovery Ecosystem Index and Settlement Fund
Tracking tools, the U.S. System of Care for Individuals
in Recovery, Emergency Department and Hospital In-patient
Services, and the Importance of MAT in the Correctional
System. The event will include academic and independent affiliate
partners such as: Georgetown University School
of Medicine, East Tennessee State
University (ETSU), Addiction Sciences Center; GATC Health;
Volunteers of America, Mid-States; Bureau of Justice Assistance,
U.S. Department of Justice; the Florida State Attorney's Office;
and Legal Services Corporation, to name a few. Equally prominent
will be highlighting the successes and challenges of ongoing opioid
litigations and the policies that have evolved to help reduce the
harms associated with drug addiction.
About GATC Health
GATC Health Corp is a science and technology company
revolutionizing disease prediction and drug discovery and
development through its transformative AI platform and approach,
which de-risks drug pipelines and accelerates new therapies to
treat disease with accuracy, efficiency and speed never before
achieved in medical science. The company's validated and
proprietary Multiomics Advanced Technology™ (MAT) platform
simulates human biochemistry's billions of interactions for
accurate and rapid disease prediction, novel target identification,
and drug discovery and development. GATC envisions the future of
medicine now, where health is protected, disease is reversed, and
every person's unique biology is treated with precision.
GATC is accelerating the future of predictive, individualized
medicine, today.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/gatc-health-to-speak-at-the-opioid-settlement-abatement-summit-in-washington-dc-301729908.html
SOURCE GATC Health Corp